[CITATION][C] SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators. Avosentan reduces albumin excretion in diabetics …

RR Wenzel, T Littke, S Kuranoff, C Jurgens, H Bruck… - J Am Soc Nephrol, 2009